20 results
DEF 14A
COYA
Coya Therapeutics Inc
19 May 23
Definitive proxy
4:31pm
Leadership Structure and Role in Risk Oversight
Evaluations of the Board of Directors
Stockholder Communications
Code of Business Conduct and Ethics
Anti … and Corporate Governance Committee may take into account many factors, including: personal and professional integrity, ethics and values; experience
10-Q
EX-10.1
3ej6 iv2n9
10 May 23
Quarterly report
7:14am
10-K
EX-3.2
b00dpe
29 Mar 23
Annual report
4:08pm
10-K
0fm352xhnw5757k
29 Mar 23
Annual report
4:08pm
424B4
m2rv2p wbf4k3
30 Dec 22
Prospectus supplement with pricing info
4:17pm
S-1/A
lspjl 6ie5m3npfd11
5 Dec 22
IPO registration (amended)
8:16am
S-1/A
EX-10.7
tmfhw9bcyu a7
5 Dec 22
IPO registration (amended)
8:16am
S-1
EX-3.4
csqed9zt2cpbgv8 6sls
18 Nov 22
IPO registration
5:06pm
S-1
xgk9rq 2ykcj
18 Nov 22
IPO registration
5:06pm
S-1
EX-10.7
ot2s 72t3eamys
18 Nov 22
IPO registration
5:06pm
DRS/A
tlm4t
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
EX-3
dv3ty9
28 Oct 22
Draft registration statement (amended)
12:00am
DRS/A
mkn73
7 Oct 22
Draft registration statement (amended)
12:00am
DRS
944c8 coz46p
19 Aug 22
Draft registration statement
12:00am
- Prev
- 1
- Next